Mastercard (MA)
Verdict history · MA
Every call Verdix has made on MA.
While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.
Click any date below to read that write-up
The prior BUY at $569.29 was predicated on having meaningful runway before the $602 all-time high, but the subsequent rise to $580.63 compressed that gap to just 3.5%, largely evaporating the asymmetry. The standing trigger for a pullback to $530-$550 never fired, so no fresh capital was deployed at a better price, and the panel shifts to BALANCED on natural asymmetry compression.
See methodology for how verdicts are produced. Full track record →
The panel’s split verdict on MA — and where they disagree.
The case for and against roughly balance — no clear edge at today's price.
NYSE · Payments / Financial Infrastructure · 2026-07-05 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
BalancedMEDIUM confidence
Why
Six investing legends on the payments duopoly after a pullback and an 8% bounce: a ~60%-margin toll bridge compounding 16%, freshly relieved of a 20-year interchange lawsuit — against a genuine long-term threat from stablecoins and agentic-commerce rails built to bypass it. Fair values straddle the price. A wonderful business at a fair price. The debate and the key levels.Level to watch
Key resistance 560+3.8% from 539.39
The panel's take
Verdict: BALANCED · Conviction: MEDIUM · Last price: USD 539.39 (as of 2026-07-05)
Mastercard is the panel's cleanest "wonderful business at a fair price" standoff — the reason the verdict lands on BALANCED rather than a buy or a sell. The quality is not in question: Q1 revenue grew 16% to $8.4B, adjusted EPS rose to $4.60, operating margin sits near 60%, free cash flow converts at ~52% of revenue (and exceeds net income — clean earnings), and the value-added-services layer (fraud, data, consulting) is compounding ~20%, diversifying the business away from pure transaction cyclicality. After a pullback from the ~$600 high to the high-$400s — driven by a specific, likely-transitory cross-border-travel softening (Middle East) — the stock has bounced 8% to $539, helped by preliminary approval of the $38B interchange settlement (lifting a 20-year legal overhang), a 14% dividend hike, and a new $14B buyback. The catch is that it's now roughly fairly valued: independent fair-value estimates straddle the price, from ~$420-450 (the valuation lens) and ~$480-510 (the forensic lens) below, to ~$540 (fundamentals) and modestly above (the value lens), with the analyst consensus up near $644. And over the debate hangs a real, unresolved question: stablecoins, real-time rails, and AI-agent commerce are built specifically to bypass the ~2-3% interchange toll, even as Mastercard spends ($1.8B on BVNK) to own the new rails rather than be disintermediated. With a durable compounder trading near fair value and a genuine long-term disruption debate that no near-term catalyst resolves, the synthesis is BALANCED — own it and monitor, neither chase nor sell.
Key levels
Key levels · MA
USD · as of 2026-07-05Analyst consensus target 644 USD · range 533–735
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance starts at ~$560 (the supply zone from the earlier breakdown, and near the 200-day the stock is testing from below), then the ~$600 all-time high, with a ~$620+ extension on new-high price discovery. Key support sits at ~$500 (a round-number prior floor), then ~$475 (the correction low and highest-volume base), with a deeper ~$440 level (roughly the 50% retracement of the multi-year advance). The analyst consensus target spans roughly USD 533 to 735, averaging near USD 644 — well above the current price (~19-20% upside) — but note the panel's own valuation and forensic lenses sit at and below the quote ($420-510), the crux of the disagreement over how much the disruption threat should discount the multiple.
What legendary investors think
We ran Mastercard past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue🟢 BullishHigh
"About as close to a toll bridge as you'll find" — a small cut of a growing river of global commerce, no loan risk. Q1 revenue +16%, EPS +23%, ~58% operating margin; ROE "looks almost absurd" from the asset-light model plus buybacks. At ~29x for a 20%+ compounder, "a fair price for a wonderful business" with a sliver of margin of safety after the pullback. The $1.8B BVNK deal is management "trying to own the new track."
The GARP OperatorGrowth (GARP)🟢 BullishMedium
A stalwart — "too big now to be a true fast grower." P/E ~29x (below its ~34x average), but durable growth is low-to-mid-teens, so "PEG near 2.1 — into expensive territory even after the pullback." The +8% bounce means "the market already sniffed out the value." A "know what you own, don't get scared out of it" hold; wants the high-$400s/low-$500s (PEG ~1.5-1.7) to add.
The Disruptive-Innovation SeekerGrowth🔴 BearishMedium
"An incumbent toll-taker sitting on a rail that stablecoins and account-to-account infrastructure are built specifically to bypass." Stablecoin volume hit ~$33T (+72%), agentic commerce is routing around card fees, and MA/V/AXP have sold off 18-23%. Management is adapting (BVNK, Agent Pay), "but adaptation into a lower-margin rails-for-stablecoins role is still margin compression versus the pure-toll model." A name to watch, not underwrite.
The Intrinsic-Value ModelerValuation🔴 BearishMedium
A DCF confirms the moat, not the price: fair value ~$420-450, roughly 15-20% below the quote. Visa is cheaper on both forward P/E and EV/EBITDA with a nearly identical profile, "so the market is paying a premium the numbers don't quite justify." Terminal disruption risk (real-time rails, stablecoins, interchange caps) is "the tail that keeps me from paying up." Prefers the $440-460 zone.
The Forensic SkepticContrarian🔴 BearishMedium
Fair value ~$480-510 on normalized (not buyback-flattered) EPS. Two flags: the June court-approved $38B interchange settlement "legislated the take-rate lower" (a 10bps cut and a 1.25% cap), and management "buying the bypass road" with BVNK tells you something about moat durability that a ~25x forward multiple doesn't yet reflect. Not a short — real multiple compression has happened — but no margin of safety at $539.
The Macro OpportunistMacro🟢 BullishMedium
"A high-quality compounder cut 25% and snapping back 8% off a washout low — worth a look, not a max bet." The business is fine (cross-border +13% local-currency says the travel consumer is healthy), but "a great business at the wrong multiple in a tightening regime still gets sold." Wants a confirmed reclaim of the 200-day (~$540-552) on volume before sizing up; stop near $460. "Own it at $460 with a tight stop, don't chase $550 into resistance."
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The business is best-in-class: ~60% operating margins, ~52% FCF conversion, clean cash-backed earnings, and a value-added-services engine growing ~20% that diversifies the revenue mix.
- The moat is a genuine duopoly with Visa — network effects, switching costs, pricing power, and almost no capital intensity.
- The valuation has reset but is fair-to-full, not cheap: ~29x TTM (below its own ~34x history), a PEG near 2, and a premium to Visa above its historical average.
- The pullback has a specific, likely-transitory cause: a Middle East-driven cross-border-travel deceleration (from +13% toward +2%), guided to persist through Q2 — not a franchise breakdown.
The real debate
- Toll bridge or disruption target? The value and fundamental lenses see a durable, widening moat; the innovation and forensic lenses see stablecoins, A2A rails, and agentic commerce built to bypass the interchange toll — with the $38B settlement already trimming the take-rate.
- Is "owning the bypass" additive or dilutive? Bulls read BVNK/Agent Pay as Mastercard capturing the new settlement layer; bears read it as a defensive move into a lower-margin role that compresses the very economics that built the multiple.
- Fairly valued or wait for cheaper? The value lens and fundamentals put fair value at or above the price; the valuation, GARP, and forensic lenses want the $440-510 zone before committing.
The question it comes down to: Is Mastercard a wide-moat compounder whose stablecoin and agentic-payment moves extend the toll bridge into the next era of commerce — or a legacy interchange-taker whose take-rate was just legislated lower and whose rails a new generation of infrastructure is built to bypass, fairly valued today with the disruption not yet in the price?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 539.39 / ~460B |
| P/E (TTM / fwd) | ~27–31x / ~25x (vs its own ~37x 10-yr average; ~21% premium to Visa) |
| Revenue (Q1 2026) | USD 8.4B (+16% reported, +12% currency-neutral); FY2025 $32.8B |
| Adjusted EPS (Q1 2026) | USD 4.60 (+18%); FY2026 consensus ~$19 |
| Operating margin / ROE | ~58-61% / ~190%+ (equity base shrunk by buybacks — not a leverage signal) |
| Free cash flow | ~USD 16-17B (FY2025, ~52% of revenue; exceeds net income) |
| Capital return / net debt | $11.7B buybacks (FY25) + new $14B authorization; 14% dividend hike; net debt ~$7.7B (trivial vs FCF) |
Figures as of Q1 2026 (reported ~April, quarter ended March 31) / June 2026; sourced from Mastercard IR/SEC filings, TIKR, Investing.com, Macrotrends, GuruFocus, MarketBeat. The ~$600→high-$400s pullback traces to a Middle East-driven cross-border-travel slowdown (GCC + Israel ≈ 6% of cross-border volume), decelerating from ~+13% to ~+2% by late April and guided to persist through Q2. ROE (~190%+) is distorted by buyback-shrunk equity, not distress. The June preliminary approval of the ~$38B Visa/Mastercard interchange settlement (a ~10bps cut over 5 years, 1.25% cap for 8 years) is contested by merchant groups; large-merchant suits continue toward 2027. Next print: July 23, 2026.
The bottom line
Mastercard is the panel's textbook BALANCED verdict: a genuinely wonderful business trading at a genuinely fair price, with a real long-term question mark that today's price neither fully discounts nor ignores. The bull facts are as clean as they come — a duopoly toll bridge with ~60% margins, ~52% free-cash-flow conversion, clean cash-backed earnings, a value-added-services engine compounding 20%, and a fortress capital-return program, all at 29x forward earnings (below its own history) after a pullback whose cause (a Middle East travel-spending air pocket) looks transitory and whose biggest legal overhang (the 20-year interchange fight) just got preliminary settlement approval. The bear facts are equally serious and genuinely structural: stablecoins ($33T of volume, +72%), account-to-account rails, and AI-agent commerce are purpose-built to bypass the interchange toll; the settlement that lifted the lawsuit also legislated the take-rate lower; and management spending $1.8B to buy a stablecoin-settlement business is either extending the moat or an admission it's under threat — the panel can't yet tell which, and neither can the market. That's why the fair-value estimates straddle the price — from ~$420 to modestly above $540, with the Street up near $644 — and why the honest verdict is neither to chase a fairly-valued compounder into resistance nor to sell a widening-moat cash machine on a threat that hasn't shown up in the numbers. What would tip it bullish is BVNK proving stablecoin settlement is additive revenue, cross-border snapping back in H2, and a clean settlement resolution; what would tip it bearish is evidence that stablecoin rails are settling merchant flows without ever touching the network. Until one of those resolves, the panel's read is to own the quality and watch the disruption — BALANCED, not a trade.
contact@verdixhq.com · Published 2026-07-05 · Prices as of 2026-07-05 · Time horizon: 3–12 months · No direct position held in MA · MA verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call MA yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NYSE · Financials / Payment Networks · 2026-07-11 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six investing legends on Mastercard, the toll-booth duopoly trading below its 200-day: 60%+ margins with cross-border and value-added services outgrowing the core, but soft near-term guidance, a broken chart, and an unresolved stablecoin/GENIUS-Act question. Wall Street targets ~20% upside; the panel's value lenses see it fairly valued. The debate and the key levels.Level to watch
Key support 515−2.2% from 526.74
The panel's take
Verdict: WAIT · Conviction: MEDIUM · Last price: USD 526.74 (as of 2026-07-11)
Mastercard is the panel's "wonderful business, wait for a cleaner setup" call. Nobody disputes the quality: it is half of a payments duopoly with a genuine toll-booth moat, 60%+ adjusted operating margins, an asset-light model, and Q1 2026 revenue up 12-16% with cross-border volume (+13%) and value-added services (+18%) both outgrowing the core payment network — a healthy, diversifying mix. That is why the value lens is constructive and the Street is near-unanimously bullish with targets implying ~20% upside. But the panel as a whole is neutral, for three concrete reasons. First, valuation: at ~30x trailing (below its own ~35x history, but not cheap), the intrinsic-value work lands around $470-520 — roughly at or just below the price, leaving thin margin of safety. Second, the tape: the stock trades below its 200-day in a Stage 3 distribution pattern, having failed to reclaim resistance on bounces, with soft Q2 guidance flagged (Middle East-related spending headwinds). Third, the structural question: the GENIUS Act (effective Jan 2027) enables stablecoin rails that could, over time, disintermediate card interchange — a threat Mastercard is hedging via its BVNK acquisition and crypto licensing, which is itself an acknowledgment the risk is real. With a fully-valued quality name, a broken tape, and an unresolved disruption debate into the July 30 print, the synthesis is WAIT.
Key levels
Key levels · MA
USD · as of 2026-07-11Analyst consensus target 645 USD · range 550–735
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance starts at ~$544 (this week's high and near-term supply), then ~$565 (the weekly Supertrend line and prior consolidation shelf — a reclaim there would repair the trend), up to the ~$605 all-time high. Key support sits at ~$515 (the short-term average and this week's low), then a ~$484 historical accumulation zone, with a deeper 2025 correction floor near ~$457. The analyst consensus target spans USD 550 to 735 — averaging near USD 645, with even the low target above the current price — a striking configuration: the Street models ~20% upside while the chart sits below its 200-day, the exact disconnect the panel is weighing.
What legendary investors think
We ran Mastercard past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue🟢 BullishMedium
"A toll bridge — a duopoly network with massive switching costs and pricing power," evidenced by a ~58% operating margin and ~46% net margin. ROE north of 200% (a buyback artifact, not leverage risk, given little net debt) confirms "a capital-light cash machine." But at ~29-30x "you're paying full price for a wonderful business; I'd want a pullback toward the mid-$400s for a real margin of safety — though I wouldn't sell what I own."
The GARP OperatorGrowth (GARP)⚫ NeutralMedium
A classic stalwart at a full price. P/E ~30-31x against ~19% blended EPS growth is a PEG near ~1.6 — "you're paying up for a wonderful, toll-booth business — fine to own, not a bargain to add aggressively." With Q2 guidance softened by Middle East cross-border headwinds, "forward growth is slower than the trailing rate: great moat, steady compounder, but at this price you're buying quality, not growth at a reasonable price."
The Disruptive-Innovation SeekerGrowth🔴 BearishMedium
"A disruption target, defensively responding." Programmable, near-zero-cost stablecoin rails are settling across multiple chains, and "on-chain settlement compresses the take-rate Mastercard has monetized for decades." The BVNK deal and crypto partnerships are "smart fast-follower moves, but margin-defense, not offense." At ~sub-2% stablecoin penetration "the S-curve favors issuers and chains capturing new TAM, not incumbents protecting old TAM" — multi-year margin-erosion risk the market hasn't underwritten.
The Intrinsic-Value ModelerValuation⚫ NeutralMedium
A DCF (~12% revenue CAGR fading toward 4% terminal, operating margin holding ~58-60%, ~8.5% WACC) yields fair value ~$470-520 — modestly below the price. "The Q1 numbers are genuinely excellent — 16% net revenue growth, 58% margin, 23% adjusted EPS growth — a toll-booth compounding beautifully. But at $527 the market pays ~30x forward for a duopoly whose growth is decelerating toward GDP-plus, and my DCF lands just below price — thin margin of safety."
The Forensic SkepticContrarian⚫ NeutralMedium
The GENIUS Act stablecoins "let large merchants and fintechs settle peer-to-peer, bypassing card rails — and Mastercard is hedging via crypto licensing, itself an admission the threat is real." But at ~30-31x, "actually ~18% below its own 3-5yr average, the market is already discounting some disintermediation risk, not ignoring it." A 40-year merchant-acceptance network "doesn't unwind in one regulatory cycle." Wants "a wider margin of safety before sizing up."
The Macro OpportunistMacro⚫ NeutralLow
"The fundamental engine isn't broken — GDV +9%, cross-border +15%, switched transactions +10% — but the tape disagrees." MA has chopped below its ~$528 200-day since early June, failing to reclaim it on bounces: "a classic distribution signature, not a breakout." Won't fight a stock stuck under its 200-day "just because the numbers look decent." Wants a decisive reclaim of $528 on volume before adding, or stands aside.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The moat is elite: a payments duopoly with 60%+ margins, asset-light scale, and cross-border (+13%) and value-added services (+18%) outgrowing the core.
- The valuation is full but not extreme: ~30x, below its own ~35x history, with the DCF roughly at the price.
- The near term is soft: Q2 guidance was cut on Middle East-related spending headwinds.
- The tape is broken: below the 200-day in a Stage 3 distribution pattern.
The real debate
- Disruptor or disruption target? The value/GARP lenses see a durable toll booth; the innovation lens sees stablecoin rails compressing interchange over time.
- Priced-in or unpriced risk? The forensic lens notes the de-rating already discounts some disintermediation; the innovation lens says multi-year margin erosion isn't underwritten.
- Street vs. tape: analysts model ~20% upside to ~$645; the chart sits below its 200-day and the DCF sits at the price.
The question it comes down to: Is Mastercard a fairly-valued, wonderful toll-booth to accumulate on weakness — or a full-priced incumbent facing a real stablecoin threat and a broken tape, where the patient move is to wait for a reclaim of the 200-day and clarity on Q2?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 526.74 / ~466B |
| P/E (TTM / fwd) | ~30-31x / ~26x (vs ~35x historical) |
| Q1 2026 revenue | USD 8.40B (+12-16% YoY); cross-border +13%, value-added services +18%, GDV +7% |
| EPS | $4.60 (+18-23% YoY); Q2 guide softened (Middle East headwinds) |
| Operating margin / ROE | ~58-61% / ~210% (buyback/negative-equity artifact) |
| Capital return | ~$4.8B returned in Q1 ($4.0B buyback + $0.8B dividends); 14 straight annual dividend raises |
| Stablecoin positioning | BVNK acquisition (~$1.5-1.8B) + crypto licensing vs GENIUS Act (effective Jan 2027) |
Figures as of Q1 2026 (reported Apr 30, 2026) / July 11, 2026; sourced from Mastercard IR/SEC filings, StockAnalysis, TIKR, Forbes, Motley Fool, MarketBeat. ROE (210%) is a buyback/negative-equity artifact, not organic efficiency. Growth is durable (cross-border +13%, value-added services +18%) but Q2 guidance softened on Middle East-related spending; the GENIUS Act stablecoin framework (effective Jan 2027) is the key structural overhang, which Mastercard is hedging via BVNK and crypto licensing. Analyst consensus ($645 avg, range ~$550-735) sits above the price even as the tape trades below its 200-day. Next print: July 30, 2026 (Q2 2026).
The bottom line
Mastercard is the panel's "great business, patient stance" call — a duopoly toll booth whose quality is beyond question but whose setup argues for waiting rather than chasing. The bull case is real: 60%+ margins, an asset-light network with decades of merchant-acceptance advantage, cross-border and value-added services both growing faster than the core, and a Street that models ~20% upside with even its low target above today's price. But the panel lands on neutral for three concrete reasons. The valuation, while below Mastercard's own history, leaves the DCF roughly at the price — no margin of safety. The tape is broken, trading below the 200-day in a distribution pattern that has rejected every bounce, with Q2 guidance already softened by Middle East spending headwinds. And the stablecoin question is genuinely unresolved: the GENIUS Act could, over years, let payments route around card interchange, and Mastercard's own crypto acquisitions concede the threat is real. What would tip the call bullish is confirmation on both fronts — a reclaim of the ~$528-565 zone on volume and a July 30 print showing cross-border and value-added services reaccelerating past the Q2 drag, with stablecoin positioning framed as offense. What keeps it a wait is that, at a full valuation with a broken chart and an unpriced structural debate, the patient move is to let the toll booth prove the disruption fear overdone before paying up.
contact@verdixhq.com · Published 2026-07-11 · Prices as of 2026-07-11 · Time horizon: 3–12 months · No direct position held in MA · MA verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call MA yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NYSE · Financials / Payment Networks · 2026-07-18 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six investing lenses on Mastercard after a 3.2% weekly move on zero new fundamental data: the Supertrend flipped bullish and price reclaimed the $528-565 zone on volume, but every lens wants the July 30 Q2 print or a clean break of resistance before paying up further. The debate and the key levels.Level to watch
Key resistance 555+2.1% from 543.6
The panel's take
Verdict: WAIT · Conviction: MEDIUM · Last price: USD 543.60 (as of 2026-07-18)
What changed since 2026-07-11:
- Price: USD 526.74 → 543.60 (+3.2%) — a technical bounce (Supertrend flipped bullish, price reclaimed the $528-565 zone on real volume) with no new fundamental data behind it.
- Panel: 1 of 6 → 0 of 6 now Bullish (2 of 6 flipped: The Moat Compounder Bullish → Neutral, The Disruptive-Innovation Seeker Bearish → Neutral) — both converged on Neutral for the same reason: the price gain outran the unchanged $470-520 DCF anchor, compressing rather than confirming the case, leaving all six lenses aligned Neutral for the first time.
- Trigger: the July 30 Q2 print (~12 days out) or a decisive break of the $555-565 resistance zone on volume — whichever resolves first.
- Verdict: WAIT (unchanged)
The synthesis holds at WAIT because a price move isn't a valuation move: paying more for the same duopoly economics as last week leaves less margin of safety, not more, even as the chart's technical picture genuinely improved. The panel is withholding conviction until one of the two pending triggers resolves the ambiguity.
Key levels
Key levels · MA
USD · as of 2026-07-18Analyst consensus target 645 USD · range 550–735
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance sits at ~$555 (R1, this week's ceiling), then ~$565 (R2, the top of the reclaimed zone), up to the ~$605 all-time high. Key support begins near ~$529 (this week's higher-low and the base of the reclaimed zone), then a ~$484 historical accumulation zone, with a deeper 2025 correction floor near ~$457. The analyst consensus target spans USD 550 to 735 — averaging near USD 645 — with even the low end of that range sitting just above the current price.
What legendary investors think
We ran Mastercard past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue/Quality/Moat⚫ NeutralMedium
"One of the finest toll-booth businesses around" — 58-61% operating margins, cross-border +13%, value-added services +18% — but "the tape moved 3.2% this week on zero new fundamental data," so the DCF anchor of $470-520 hasn't budged while price ran to $543.60. "I don't pay up for a good business ahead of confirmation"; wants the Q2 tape or a pullback toward $515-529 first.
The GARP OperatorGrowth (GARP)⚫ NeutralMedium
"A wonderful business... a duopoly toll booth" with the same 58-61% margins and 13%/18% growth lines, and the tape gave half the trigger — a reclaim of $528-565 on real volume with the Supertrend flipping bullish. But "the DCF anchor sits at 470-520 while the stock ran 3.2% further away from it... that's the PEG-style math getting worse, not better, on hope alone." Wants R1 ($555) taken out on volume, or the July 30 print.
The Disruptive-Innovation SeekerDisruptive Innovation⚫ NeutralLow
A "quality duopoly compounder" but "not where exponential innovation platforms live" — the GENIUS Act (effective Jan 2027) and the ~$1.5-1.8B BVNK bet read as "Mastercard hedging against the S-curve I actually want exposure to, not riding it." At $543.60 against a DCF anchor of $470-520, "the market is paying a premium for the old rails while the new ones are still being built."
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralMedium
The DCF anchor of $470-520 "was already set against last week's $526.74 close, and now sits further beneath today's $543.60" on zero new information. The Supertrend flip and reclaim of the $528-565 zone on volume are real, "but a technical signal isn't a valuation argument," and ~31-32x trailing against a $550 analyst-target floor "leaves little room for error" ahead of the July 30 print.
The Forensic SkepticContrarian/Forensic⚫ NeutralMedium
"The footnote here is that nothing fundamental changed this week" — price moved 3.2% on zero new data, compressing rather than improving the margin of safety. The tape "stalled well short of clearing R1 ($555), let alone R2 ($565)" — a partial trigger, not confirmation. Won't pay ~31-32x trailing with the analyst low-end target ($550) already in spitting distance of spot, 12 days ahead of the Q2 print.
The Macro OpportunistMacro/Timing⚫ NeutralLow
The tape gave "half of what I asked for" — Supertrend bullish, the $528-565 zone reclaimed on real volume, closing at 543.60 after a 552 high — but "I'm not paying up for a move that hasn't cleared R1 at 555, let alone R2 at 565." Fundamentally, "the stock ran 3.2% further away from [fair value] on zero incremental information." Wants the 555-565 breakout on volume, or a higher-low above 529, before calling it a swing.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- Business quality is undisputed across all six lenses: 58-61% operating margins, cross-border volume +13%, value-added services +18%.
- Price moved 3.2% this week on zero new fundamental data, so the intrinsic-value anchor of $470-520 hasn't moved even as price ran further from it — the margin of safety has compressed, not improved.
- The tape gave a partial confirmation — Supertrend flipped bullish, price reclaimed the $528-565 zone on real volume — but stalled short of clearing resistance at $555 (R1) and $565 (R2).
- Nearly every lens treats the July 30 Q2 print, still roughly 12 days out, as the actual confirming or disconfirming event.
The real debate
- Toll booth or disruption target? The Disruptive-Innovation Seeker sees Mastercard's stablecoin hedge (GENIUS Act, BVNK) as defense against the real S-curve it would rather own directly; the value/GARP-style lenses treat that threat as background noise this week, unmoved from the underlying moat.
- Technical confirmation vs. valuation stretch: The GARP Operator and Macro Opportunist frame the Supertrend flip and volume as the start of a genuine reclaim — worth backing once resistance clears; the Intrinsic-Value Modeler and Forensic Skeptic read the same move as the market pricing hope into an unconfirmed print, arguing the chart has gotten ahead of the fundamentals.
The question it comes down to: Does the reclaim of the $528-565 zone mark the start of a confirmed uptrend once resistance at $555-565 breaks — or is the tape getting ahead of a still-unconfirmed Q2 story, twelve days before the print settles it?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 543.60 / ~481B |
| P/E (TTM / fwd) | ~31-32x / ~27x (vs ~35x historical) |
| Q1 2026 revenue | USD 8.40B (+12-16% YoY); cross-border +13%, value-added services +18%, GDV +7% |
| EPS | $4.60 (+18-23% YoY); Q2 guide softened (Middle East headwinds); Q2 print due July 30, 2026 |
| Operating margin / ROE | ~58-61% / ~210% (buyback/negative-equity artifact) |
| Capital return | ~$4.8B returned in Q1 ($4.0B buyback + $0.8B dividends); 14 straight annual dividend raises |
| Stablecoin positioning | BVNK acquisition (~$1.5-1.8B) + crypto licensing vs GENIUS Act (effective Jan 2027) |
Figures as of Q1 2026 (reported Apr 30, 2026) / July 18, 2026; sourced from Mastercard IR/SEC filings, StockAnalysis, TIKR, Forbes, Motley Fool, MarketBeat. Price moved +3.2% week-over-week (from USD 526.74 on July 11) on no new fundamental data; the DCF fair-value anchor remains USD 470-520, unchanged from last week. ROE (~210%) is a buyback/negative-equity artifact, not organic efficiency. Next print: July 30, 2026 (Q2 2026).
The bottom line
The two pending triggers are independent and could resolve in either order. A clean break above $565 (R2) on volume would confirm this week's reclaim as more than a bounce; the July 30 print — specifically whether cross-border and value-added services reaccelerate past the Q2 guidance cut, and whether the stablecoin hedge starts reading as offense rather than defense — would confirm or break the fundamental side. A slip back below $529 (S1) before either trigger lands would flag the reclaim as a false move, pulling attention back toward the $484 accumulation zone. Absent one of those, expect the panel to hold at WAIT through the print.
contact@verdixhq.com · Published 2026-07-18 · Prices as of 2026-07-18 · Time horizon: 3–12 months · No direct position held in MA · MA verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call MA yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NYSE · Financials / Payment Networks · 2026-07-25 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six investing lenses hold Mastercard at Neutral for a second straight week after a quiet -0.7% pullback on zero new fundamental data, with the July 30 Q2 print and an untested $555 resistance level still the only things that can resolve the standoff. A newly priced Fed-hike risk at the July 28-29 FOMC and a small, unexplained analyst price-target trim add noise without moving the underlying case, while trailing revenue and earnings growth both kept accelerating. The debate and the key levels.Level to watch
Key support 528−2.2% from 539.66
The panel's take
Verdict: WAIT · Conviction: MEDIUM · Last price: USD 539.66 (as of 2026-07-25)
What changed since 2026-07-18:
- Price: USD 543.60 → 539.66 (-0.7%) — a shallow pullback, not a reversal. The prior week's low briefly wicked to 523.61 intraweek before closing back inside the reclaimed zone, a tested-not-broken support read.
- Panel: 0 of 6 → 0 of 6 Bullish — composition and conviction held static for the first time in the log (all six lenses stay Neutral: four Medium, two Low). The Macro Opportunist is the only lens introducing a genuinely new consideration — markets are now pricing roughly a one-third chance of a Fed hike at the July 28-29 FOMC, two days ahead of Mastercard's own print.
- Catalyst: the July 30 Q2 print, now 5 days out (was 12), plus the newly relevant July 28-29 FOMC decision landing first.
- New data points: The Forensic Skeptic flags an unexplained Truist price-target trim ($561 → $554, rating held at Buy) as pre-earnings noise rather than signal. Offsetting that, trailing fundamentals kept accelerating (TTM revenue +16.8% YoY, TTM EPS +21.2% YoY) and the sell-side consensus target firmed modestly (mean clustering ~$644-655 vs last week's ~$645 average, 35 of 38 rated buy-or-outperform, zero sells).
- Verdict: WAIT (unchanged)
The synthesis holds at WAIT because five trading days produced drift, not data: price gave back less than a percent, the DCF anchor of $470-520 didn't move because nothing happened to move it, and the two pending triggers — a clean break of $555-565 resistance, or Thursday's print — are both still open. The one new element, a live FOMC decision landing two days before Mastercard's own numbers, adds a macro variable none of the six lenses were pricing last week, but it changes the shape of the wait, not its direction.
Key levels
Key levels · MA
USD · as of 2026-07-25Analyst consensus target 650 USD · range 550–735
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Resistance is unchanged this week — the highest print since the last article was 551.72, and the most recent completed week only reached 547.91, so neither R1 ($555) nor the deeper R2/R3 bands have been tested. Support gets a small, deliberate widen: a brief intraweek dip to 523.61 that closed back inside the zone pushes S1 from 526-532 to a slightly wider 523-532, reflecting the tested low without treating it as a breakdown. S2 ($484, the March 2026 base) and S3 ($457, the 2025 correction floor) remain untested and unchanged. The analyst consensus target band nudges up slightly on a firmer sell-side mean ($644-655 across roughly 38-41 analysts), with the low end of the broader range still sitting above the current price.
What legendary investors think
We ran Mastercard past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue/Quality/Moat⚫ NeutralMedium
Same 58-61% operating margins, same duopoly moat, same $470-520 DCF anchor — "a pullback that takes price closer to my anchor is more interesting than a rally that takes it further away, but a few dollars of drift isn't a re-rate." The CFO/CBO leadership shuffle and confirmed dividend are "housekeeping, not fundamentals." Holds Neutral into the July 30 print.
The GARP OperatorGrowth (GARP)⚫ NeutralMedium
Price is "still boxed inside the $528-565 reclaimed zone, still short of R1 at $555, still above S1" on no new print. "A wonderful business trading at a full price isn't a bargain just because the chart cooled off for a week." Wants cross-border/value-added-services reacceleration on the print, or R1 taken on volume.
The Disruptive-Innovation SeekerDisruptive Innovation⚫ NeutralLow
Nothing structural changed — no new stablecoin-rail data, no BVNK integration update. "The market is still pricing MA as a toll-booth compounder, not a disruption vector — which is my whole point." Still watching for the crypto-licensing push to read as offense rather than defense against the GENIUS Act S-curve.
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralMedium
"A stock trading a hair below where it closed last week is not a story — it's noise, and I don't update valuations on noise." The $470-520 anchor is unchanged because there's zero new operating data; the stablecoin/BVNK question "is still narrative" until it shows up in a reinvestment rate or a margin line, not before.
The Forensic SkepticContrarian/Forensic⚫ NeutralMedium
"A price target trimmed without a stated reason, five days before the number that actually matters, is noise dressed as signal — I'm not paying for noise." The stock stalled rather than broke out, reading as the market also waiting on July 30 rather than front-running it. Same $470-520 anchor, same ~31-32x trailing multiple.
The Macro OpportunistMacro/Timing⚫ NeutralLow
"I don't care how good the toll booth is if the Fed is about to make money more expensive and energy is dragging the consumer's wallet the other way." A ~31-32x multiple on a payments compounder "is a bet on smooth global consumption growth" — now walking into live FOMC hike risk two days before its own print even lands.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- Business quality remains undisputed across all six lenses: 58-61% operating margins, and trailing revenue/EPS growth both accelerated (TTM revenue +16.8% YoY, TTM EPS +21.2% YoY).
- Price drift of -0.7% this week reads as noise, not signal, to every lens — nobody moved the $470-520 DCF anchor, and nobody treats a sub-1% move as data.
- All six lenses are unanimously Neutral for a second straight week — the first fully static conviction read in the log, with no flips in either direction.
- The July 30 Q2 print is treated across the board as the actual confirming or disconfirming event, now days rather than weeks away.
The real debate
- Toll booth or disruption target? The Disruptive-Innovation Seeker still reads Mastercard's stablecoin/BVNK positioning as defense against the S-curve it would rather own directly; the value/GARP-style lenses continue to treat that as background noise, unmoved from the underlying moat.
- Noise vs. signal on the Truist trim: the Forensic Skeptic explicitly refuses to read the unexplained $561→$554 price-target cut as anything but pre-earnings positioning, while the still-Strong-Buy consensus (mean ~$644-655) is treated by the value-oriented lenses as the more reliable data point.
- A wildcard nobody else is pricing: the Macro Opportunist is alone in weighting the July 28-29 FOMC decision as a factor that could reprice the setup before Thursday's earnings even matter — the other five lenses stay company-specific and don't fold Fed-meeting risk into their read at all.
The question it comes down to: Does the July 30 print — or a clean break above $555-565 — finally confirm the reclaim as more than a bounce, or does a hawkish FOMC surprise two days earlier undercut the setup before Mastercard's own numbers get a chance to speak?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 539.66 / ~477B |
| P/E (TTM / fwd) | ~31.2x / ~26.7x (vs ~35x historical) |
| TTM revenue / net income | USD 33.94B (+16.8% YoY) / USD 15.57B (+18.5% YoY) |
| TTM EPS | USD 17.29 (+21.2% YoY); Q2 2026 print due July 30, 2026 (consensus ~$4.75-4.77 EPS) |
| Operating margin / ROE | ~58-61% / ~210% (buyback/negative-equity artifact) |
| Capital return | $0.87/share quarterly dividend declared, paid Aug 7; 14 straight annual dividend raises |
| Stablecoin positioning | BVNK acquisition (~$1.8B, regulatory approval expected late 2026) + Agent Pay (launched June 2026) vs GENIUS Act (effective Jan 2027) |
Figures as of July 25, 2026 (TTM basis) and July 24, 2026 (technical close); sourced from Mastercard IR/SEC filings, StockAnalysis, TIKR, TipRanks, MarketBeat, TradingView. Price moved -0.7% week-over-week (from USD 543.60 on July 18) on no new fundamental data; the DCF fair-value anchor remains USD 470-520, unchanged from last week. ROE (~210%) is a buyback/negative-equity artifact, not organic efficiency. Next print: July 30, 2026 (Q2 2026), preceded by the July 28-29 FOMC meeting.
The bottom line
Two catalysts now sit ahead of resolution, in a new order: the July 28-29 FOMC decision lands first, and a hawkish surprise — a hike where markets are pricing roughly one-in-three odds — could move the whole setup's multiple before Thursday's Mastercard-specific numbers even get read. Absent that, the July 30 print remains the primary trigger — specifically whether cross-border and value-added-services growth reaccelerate past the softened Q2 guide. A clean, volume-confirmed close above $555 (R1) would independently confirm this month's reclaim as more than a stall; a slip back below $523 (the newly widened S1) before either trigger resolves would flag the reclaim as a false move and put the $484 accumulation zone back in view. Absent one of those, expect the panel to hold at WAIT through the print.
contact@verdixhq.com · Published 2026-07-25 · Prices as of 2026-07-25 · Time horizon: 3–12 months · No direct position held in MA · MA verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call MA yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NYSE · Financials · 2026-08-01 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six investing archetypes weigh Mastercard at $573: the business earns near-universal praise for its toll-booth economics, 46% net margins, and an 18%-growing services division, but the panel splits 3–3 on whether this price offers an edge. The verdict is WAIT — the bulls say fair value for a compounding machine, the cautious camp says no-man's-land between support at $528–$533 and resistance at $602.Level to watch
Key support 569.38−0.6% from 573.1
The panel's take
Verdict: WAIT · Conviction: MED · Last price: USD 573.1 (as of 2026-08-01)
What changed since 2026-07-25:
- Price: USD 539.66 → USD 573.1 (+6.20%)
- Panel: 0 of 6 → 3 of 6 now Bullish — composition also changed: added The Asymmetric Bargainer, The Scuttlebutt Growth Investor; removed The Disruptive-Innovation Seeker, The Forensic Skeptic
- Trigger: BUY on a weekly close above $602 (ATH breakout confirmation with expanding volume) OR on a pullback into the $528–533 confluence zone (weekly EMA50, monthly EMA20, weekly Fib 50%). SELL if the business thesis cracks: weekly close below $528 (Stage 2 structural breakdown) or revenue growth drops below 10% for two consecutive quarters.
- Verdict: WAIT (unchanged)
Three months ago at $539.66, the panel was unanimously cautious with zero bullish voices — the question was whether the price had fallen enough. Now at $573.10, the stock has rallied 6.2% and three of six voices have turned bullish on the business, yet the verdict remains WAIT because price has moved into a no-man's-land: too high for the bargain hunters who want $528–$533, and not yet breaking $602 to confirm a new markup phase. The addition of The Scuttlebutt Growth Investor and The Asymmetric Bargainer sharpened the debate without resolving it — one sees perfection worth paying for, the other sees no asymmetric payoff worth chasing.
This is a classic BUY-vs-WAIT split: every voice — bulls included — agrees Mastercard is a world-class compounder, but the cautious camp (technical-scout, The Intrinsic-Value Modeler, The Asymmetric Bargainer, The Macro Opportunist) is united on one objection: price and timing, not the business. No voice questions the moat, margins, or growth runway. The verdict is WAIT, not HOLD, because the blocker is purely entry-level (monthly MACD bearish cross, price stuck mid-range at $573, no catalyst pending), and two specific triggers are identifiable: a breakout above $602 or a pullback to the $528–533 support zone.
Key levels
Key levels · MA
USD · as of 2026-08-01Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran Mastercard past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralMed
Signal: A DCF using 14% revenue growth stepping down to 10% over six years and a 50% target EBIT margin yields a fair value of $565, placing the stock roughly 1.4% overvalued at $573, which means the market is pricing in the base case, not the bull case, and offers no margin of safety. Conviction: Conviction is held back by the dependency on margin estimates: even a 500bps compression to 50% shaves $15 off fair value, and regulatory pressure makes margin erosion a question of when, not if.
The GARP OperatorGrowth (GARP)🟢 BullishMed
Signal: With a PEG ratio of roughly 1.2 against 20–23% EPS growth, Mastercard is the rare 'wonderful company at a fair price' — not a bargain, but fairly priced for the quality of its toll-booth economics and 45.9% net margins. Conviction: Conviction is reinforced by multiple independent facts: 18% VAS growth as a second engine, real cash-backed earnings with robust FCF, a self-reinforcing two-sided network moat, and a balance sheet with negligible debt stress at 0.62x net debt/EBITDA.
The Moat CompounderValue/Quality/Moat🟢 BullishMed
Signal: Mastercard's two-sided network connecting 3.3 billion cardholders to millions of merchants is one of the widest, most self-reinforcing moats in any financial company, with Value-Added Services digging that moat deeper every year at 18% growth. Conviction: Conviction is moderated only by price: at 31x trailing earnings the business is not cheap, and the preference is to accumulate on a pullback to the $530 area rather than chase at $573.
The Scuttlebutt Growth InvestorGrowth/Management🟢 BullishHigh
Signal: Scoring a rare 15 out of 15 on the Fisher checklist, Mastercard pairs a multi-decade cash-to-digital runway with 18% VAS growth, 45.9% net margins, and a management team that consistently demonstrates integrity, long-term thinking, and excellent capital allocation. Conviction: Conviction is exceptionally high because the checklist is unanimous across all 15 dimensions — market potential, R&D effectiveness, margin trends, management candor, and competitive advantages are all confirmed by independent evidence with no weak points.
The Asymmetric BargainerContrarian/Deep Value⚫ NeutralMed
Signal: The Dhandho framework passes only two of four tests — simple business and favorable odds — but fails on both limited downside and substantial upside: at 31x earnings, a de-rating to 25x would cost ~20%, while analyst targets imply only ~15% upside, producing no asymmetric payoff. Conviction: Conviction on the neutral call is strengthened by multiple independent signals: no superinvestor cloning opportunity exists as hedge funds trimmed 3.9 million shares last quarter, the monthly MACD shows a bearish cross, and the stock sits mid-range with no distress-driven mispricing to exploit.
The Macro OpportunistMacro/Timing⚫ NeutralMed
Signal: The monthly MACD has printed a bearish crossover with a negative histogram of -7.15 while the weekly MACD shows a bullish flip, and this timeframe disagreement means the stock is in a coil — consolidating in the $515–$602 range for 18 months — offering no edge at mid-range $573. Conviction: Conviction on waiting is high because multiple independent signals align: hedge funds shed 3.9 million shares, volume shows subtle bearish divergence with declining up-day participation, and the fundamental engine is accelerating (VAS +18%, cross-border +13%) while the stock consolidates — a setup that resolves explosively but unpredictably.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- Every archetype agrees Mastercard is a world-class business with an exceptionally durable moat — the two-sided network connecting 3.3 billion cardholders to millions of merchants is self-reinforcing and nearly impossible to replicate.
- All six voices recognize Value-Added Services (growing at 18% and now over 35% of revenue) as a genuine second growth engine that deepens the competitive advantage beyond transaction processing.
- No voice disputes the quality of the financials: 45.9% net margins, 83% gross margins, 232% ROE, and robust free cash flow conversion confirm the earnings are real and the business is capital-light.
- There is unanimous agreement that the secular cash-to-digital payments shift has decades of runway remaining, particularly in developing markets.
- All four cautious voices object on price and timing, not on business quality — and even the three bullish voices acknowledge the current price is fair rather than cheap.
The real debate
- The Scuttlebutt Growth Investor sees a perfect 15/15 checklist and is willing to pay the current price for a business that can compound at 15%+ for a decade, while The Asymmetric Bargainer counters that '15% upside does not move the needle' and requires a 50–100% expected return before committing capital.
- The Macro Opportunist respects the monthly MACD bearish cross as the single most important fact — 'I've made a lot of money respecting that signal in mature uptrends' — whereas The Moat Compounder barely weighs technicals, focusing instead on the moat's widening trajectory and saying 'the price you pay matters less than the quality you get.'
- The GARP Operator calls the PEG of ~1.2 fair and sees the forward P/E of 23.9x as reasonable for 20%+ EPS growth, while The Intrinsic-Value Modeler's DCF says the stock is 1.4% overvalued even in the base case and requires a pullback to $520–$530 for a margin of safety.
The question it comes down to: Can Mastercard sustain its premium multiple — currently 31x trailing and 24x forward earnings — through the regulatory and competitive headwinds (swipe-fee caps, stablecoins, real-time payment rails) long enough for the accelerating VAS and cross-border engines to grow the business into a valuation that today offers no margin of safety?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 573.1 / n/a |
| P/E (TTM / fwd) | 31.4x / 23.9x |
| ROE | 232.1% |
| Operating margin | n/a |
| Dividend yield | n/a |
| Debt / equity | 2.82x |
| Free cash flow | n/a |
Figures as of 2026-08-01; sourced from alcapitaladvisory.com and stockanalysis.com fundamental data.
The bottom line
Mastercard will tip to BUY on one of two specific triggers: a weekly close above $602 with expanding volume, which confirms the breakout from an 18-month consolidation range and opens a path to the $660–$700 analyst consensus target zone. Alternatively, a pullback into the $528–$533 confluence zone — where the weekly EMA50, monthly EMA20, and weekly Fibonacci 50% all stack — would provide a genuine margin of safety and has drawn interest from three of the six voices as an accumulation area. The SELL trigger is a weekly close below $528, which would fracture the Stage 2 uptrend structure and likely send the stock toward $470–$490. On fundamentals, watch for Q3 2026 revenue growth: if it prints below 10% year-over-year for a second consecutive quarter, the premium multiple comes under direct threat regardless of where the chart sits.
contact@verdixhq.com · Published 2026-08-01 · Prices as of 2026-08-01 · Time horizon: 3–12 months · No direct position held in MA · MA verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call MA yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NYSE · Financials · 2026-08-09 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six investing archetypes unanimously agree Mastercard is one of the world's best businesses: a global payments duopoly with 60% margins and a 241% ROE, but the entire panel splits on whether $563 is the right price to pay for it. With the stock range-bound between $530 and $602, a DCF pointing to fair value, and macro liquidity still tightening, the verdict is WAIT: buy the dip below $530 or the breakout above $602, but don't chase the middle.Level to watch
Key resistance 569.38+1.1% from 562.95
Next catalyst
The breakout trigger: A weekly close above $601.77 (the all-time high) on volume that exceeds the 50-day average. This would confirm the Stage 2 continuation and silence the monthly MACD bearish divergence that's holding back conviction.The panel's take
Verdict: WAIT · Conviction: MED · Last price: 562.95
What changed since 2026-08-01:
- Price: 573.1 → 562.95 (-1.77%)
- Panel: 3 of 6 → 2 of 6 now Bullish — composition also changed: added The Quality Rationalist; removed The Asymmetric Bargainer
- Trigger: BUY on a pullback to the $480–$530 zone (P/E compressing to 25–28x, offering 15%+ margin of safety), OR on a weekly close above $601.77 (ATH) with volume confirming the Stage 2 continuation and monthly MACD alignment. SELL if weekly close below $529.84 breaks the EMA20/50 cluster and resets the re-acceleration thesis.
- Verdict: WAIT (unchanged)
The prior WAIT verdict in early August was anchored at a slightly higher $573 price with a panel that included The Asymmetric Bargainer, a bargain-hunting voice that reinforced the margin-of-safety objection. Now, with the stock $10 lower at $563 and The Asymmetric Bargainer replaced by The Quality Rationalist (who also objects on price), the fundamental argument is unchanged: Mastercard remains a wonderful business, but every cautious voice on the panel still sees no margin of safety above $530, and the 1.77% price dip hasn't been deep enough to flip the call. The composition shift from one bargain-hunter to another quality-focused skeptic leaves the conviction at MEDIUM. The business is never the question; the entry price always is.
Every cautious voice, and even several bullish ones, agrees Mastercard is a wonderful business; the sole objection is entry price. This is a textbook BUY vs WAIT split: 3 bulls want to own it, but the preponderance of 6 cautious voices says $563 offers no margin of safety. WAIT, not HOLD, because the business itself is unquestioned and specific lower entry levels ($480–$530) are identified across multiple voices.
Key levels
Key levels · MA
USD · as of 2026-08-09Key support & resistance — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran Mastercard past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue/Quality/Moat🟢 BullishMed
Signal: Mastercard is one of the widest-moat businesses in the world, a global duopoly generating 60% operating margins, a 241% ROE, and 97% free cash flow conversion, yet at 31.5x trailing earnings, the market is charging a premium that leaves virtually no margin of safety for a new buyer. Conviction: A single unresolved tension caps this: business quality is near-perfect (10/10) but valuation is mediocre (5/10), and valuation always matters, even for a toll bridge.
The GARP OperatorGrowth (GARP)⚫ NeutralMed
Signal: The PEG ratio of 1.76x means you're paying 76% above the growth rate for a stalwart that's already a $493 billion company, and while the two-minute story is intact (they process card payments), the easy gains off the $464 low are already made. Conviction: The entire investment case rests on one assumption, and that's what keeps this in check: mid-teens growth has to persist long enough to justify the premium, and if revenue growth slips below 10%, the PEG math unravels fast.
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralMed
Signal: Even assuming 12% revenue growth fading to 8% over six years with a 55% operating margin and an 8.5% cost of capital, the base-case DCF points to roughly $550 per share, a mere 2% downside to the current $563 price. Conviction: The range of outcomes is simply too wide right now: the bull case ($680) and bear case ($420) are both plausible, but neither is clearly signaled by current data, making this a coin flip rather than a fat pitch.
The Quality RationalistMental Models/Quality⚫ NeutralMed
Signal: This is a truly wonderful business, one of the widest moats I've ever seen, but at 31.5x earnings with a 92% analyst Strong Buy consensus and net insider selling, the price already reflects too much collective optimism. Conviction: Multiple independent facts support the quality assessment (241% ROE, 97% FCF conversion, 1.14x Debt/EBITDA), but the valuation question rests on a single contested assumption: whether premium compounding justifies a premium multiple in a maturing uptrend.
The Scuttlebutt Growth InvestorGrowth/Management🟢 BullishMed
Signal: Mastercard scores a rare 15/15 on the qualitative checklist, with a $125 trillion B2B payments TAM, cross-border volume growing 14%, and value-added services reaching 37% of revenue, which means this is the kind of once-in-a-decade holding where premium pricing is warranted, not disqualifying. Conviction: What lifts this is a qualitative case reinforced by multiple independent, hard-to-dispute facts: elite management, durable network effects, and structural tailwinds, leaving valuation as the only point of debate.
The Macro OpportunistMacro/Timing⚫ NeutralMed
Signal: At $570, the upside-to-downside ratio is 0.8:1 (5.6% upside to the all-time high at $602 versus 7% downside to the EMA20/50 support cluster at $530), and the monthly MACD bearish divergence suggests the easy money from the $464 low has already been made. Conviction: The macro-liquidity picture is the drag here: QT is still draining reserves, high rates remain a headwind for long-duration assets like MA, and the one-sided analyst sentiment (38 of 41 Strong Buy/Buy) signals consensus crowding, not opportunity.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- Every voice on the panel, bullish and cautious alike, agrees Mastercard is a truly exceptional business: a global duopoly with an asset-light tollbooth model, 60% operating margins, a 241% ROE, and 97% free cash flow conversion.
- All six archetypes acknowledge the secular tailwinds are real: cash-to-digital conversion, cross-border volume growth of 14%, value-added services now 37% of revenue, and the $125 trillion B2B payments TAM provide a multi-decade growth runway.
- Every panelist agrees that at 31.5x trailing earnings, the stock is priced at a premium. The only disagreement is whether that premium is justified given the quality.
- The technical picture is universally read the same way: the stock is range-bound between $530 support (EMA20/50 cluster) and $602 resistance (all-time high), with no clear directional edge.
The real debate
- The Scuttlebutt Growth Investor sees a 15/15 qualitative score as justification for paying the premium (a once-in-a-decade holding where valuation is secondary to quality), while The Macro Opportunist counters that in a late-cycle macro environment with QT still draining liquidity, paying 31.5x for a long-duration asset exposes capital to an unfavorable balance of upside and downside.
- The Intrinsic-Value Modeler's DCF lands at $550 (essentially fair value) with growth decelerating to 4% terminal, but The Moat Compounder and The Quality Rationalist both argue that even fair value is insufficient: wonderful businesses need to be bought at wonderful prices, and that requires at least a 15% margin of safety, a level not available above $480.
- The GARP Operator and The Quality Rationalist both flag the 92% Strong Buy analyst consensus and net insider selling as warning signs that optimism is fully priced in, whereas The Scuttlebutt Growth Investor sees the same insider holdings as aligned (CEO holds ~$50M) and the analyst enthusiasm as a reflection of genuine business momentum, not a contrary signal.
The question it comes down to: Can Mastercard's mid-teens revenue growth and expanding value-added-services mix sustain the current 31.5x multiple through a maturing economic cycle, or will the law of large numbers, regulatory headwinds, and QT-driven liquidity tightening compress the multiple before the fundamentals catch up?
The bottom line
- The breakout trigger: A weekly close above $601.77 (the all-time high) on volume that exceeds the 50-day average. This would confirm the Stage 2 continuation and silence the monthly MACD bearish divergence that's holding back conviction.
- The pullback that flips it: A move into the $480–$530 zone, compressing the P/E to 25–28x, which would provide the 15%+ margin of safety that The Moat Compounder, The Intrinsic-Value Modeler, and The Quality Rationalist all require to turn bullish.
- Line in the sand: A weekly close below $529.84 (breaking the EMA20/50 support cluster) would reset the re-acceleration thesis and open downside to the weekly 200-day moving average near $502, then the swing low at $464.
- Growth rate to watch: Revenue growth slipping below 10% in any quarter is the number The GARP Operator identifies as the tripwire: at 31.5x earnings, the entire valuation rests on sustained double-digit expansion, and a break below that threshold would force a multiple re-rating.
contact@verdixhq.com · Published 2026-08-09 · Prices as of 2026-08-09 · Time horizon: 3–12 months · No direct position held in MA · MA verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s case for MA — and where they disagree.
The case for outweighs the case against at today's price.
NYSE · Financials · 2026-08-15 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
BuyMEDIUM confidence
Why
Mastercard divides the panel into four bulls who see a rare convergence of peak fundamentals and a 5-year-low multiple, and two cautious voices who argue the price is fair rather than cheap. The debate turns on whether the stock's premium multiple is structural or set to mean-revert higher as services revenue expands — and whether patience for a pullback toward the $530–$550 accumulation zone is discipline or missed opportunity.Level to watch
Key resistance 569.38+0.0% from 569.29
Next catalyst
Trigger to confirm the breakout: A weekly close above the all-time high at $601 would resolve the monthly MACD bearish crossover and signal that the uptrend is still in its early innings, not its late ones.The panel's take
Verdict: BUY · Conviction: MED · Last price: 569.29 · Changed from WAIT
What changed since 2026-08-09:
- Price: 562.95 → 569.29 (+1.13%)
- Panel: 2 of 6 → 4 of 6 now Bullish — composition also changed: added The Forensic Skeptic; removed The Macro Opportunist
- Trigger: To SELL: a weekly close below $529.60 (breaking both monthly EMA20 and weekly EMA50, confirming the monthly MACD bearish crossover), OR material US/EU interchange-fee regulation that impairs revenue guidance, OR net margins compressing below 40% signaling the tokenization defense is failing. To raise conviction to HIGH/aggressive BUY: a pullback to $530–$550 (the EMA cluster zone), which would compress the P/E toward 25-27x and provide genuine margin of safety on a wide-moat compounder.
- Verdict: WAIT → BUY
The panel flipped from WAIT to BUY because the addition of The Forensic Skeptic's cautious voice was outweighed by the four bulls converging on the same signal from different frameworks: a 5-year low multiple against peak fundamentals. The previous WAIT reflected a more balanced split when The Macro Opportunist sat in the panel; the current composition tilts decisively toward the view that quality at a reasonable price has finally arrived, though the dissenters keep conviction at MEDIUM rather than HIGH.
The panel divides into four genuine Bulls (fundamental-scout, The Intrinsic-Value Modeler, The GARP Operator, The Scuttlebutt Growth Investor, plus The Quality Rationalist who is bullish but price-sensitive) and two cautious voices. Of the cautious: technical-scout's objection is purely PRICE/TIMING ('great business, wrong entry — wait for $530 or $594'), while The Forensic Skeptic's objection is a mix of BUSINESS/VALUATION (insufficient margin of safety, crowded consensus, but he concedes the business is 'wonderful' and his own DCF at 7% growth yields $580, right at today's price). The BUSINESS objection is thin: The Forensic Skeptic's bear case is a 25x normalized P/E that would still be premium to the S&P, his intrinsic range is $600-$650 (above today's price), and his DCF at $580 roughly matches current price. Meanwhile, the four unabashed Bulls present a rare convergence: a 15-point The Scuttlebutt Growth Investor checklist sweep, a 30% The Intrinsic-Value Modeler upside, a 5-year-low multiple against all-time-high fundamentals, and a 9/10 fundamental score. The weight of the evidence sits with the Bulls — but the conviction is MED, not HIGH, because The Quality Rationalist and The Forensic Skeptic are right that this is 'fair price for a wonderful business,' not 'cheap.'
Key levels
Key levels · MA
USD · as of 2026-08-15Key support & resistance — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran Mastercard past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue/Quality/Moat⚫ NeutralMed
Signal: Mastercard's two-sided network, reinforced by the 'Tokenization for All' initiative that deepens switching costs for both merchants and consumers, creates a toll-bridge moat that is nearly impossible to disrupt, with operating margins near 60% and FCF conversion above 47% confirming the economics are real and widening. Conviction: Conviction is held back because at 31x trailing earnings the margin of safety is thin: a stumble in cross-border volumes or a macro shock leaves little room for error, and the 93% analyst buy-rating with sub-1% short interest signals that everyone is already in the boat.
The Intrinsic-Value ModelerValuation/DCF🟢 BullishMed
Signal: The market is pricing in a revenue-growth deceleration far steeper than warranted: value-added services, now 37% of revenue and carrying structurally higher margins than core switching, create a mix-shift tailwind that pushes my base-case intrinsic value to $745, a 31% discount to today's price. Conviction: Conviction strengthens because the disconnect rests on multiple independent pillars: a 5-year low P/E against all-time-high margins, a self-reinforcing network moat no competitor can replicate from scratch, and services revenue that acts as a hidden margin accelerant most consensus models underweight.
The GARP OperatorGrowth (GARP)🟢 BullishHigh
Signal: Mastercard screens as a Stalwart with Fast-Grower characteristics: the trailing P/E of 31x sits below the three-year average of 38x while operating margins have climbed from 54% to 60% over five years, meaning you are buying a better company at a cheaper price for the first time in half a decade. Conviction: Confidence runs high because the bull case does not depend on a single heroic assumption: the PEG of 1.61 is reasonable for a wide-moat compounder, the services pivot at 37% of revenue adds a hidden-asset dimension, and management has shrunk the share count by over 100 million shares in five years without adding leverage risk.
The Scuttlebutt Growth InvestorGrowth/Management🟢 BullishHigh
Signal: This is a 15-for-15 on the The Scuttlebutt Growth Investor checklist, a rare perfect score driven by a two-sided network moat that no rational entrant can replicate, services revenue growing faster than the core business and lifting margins, and management that has compounded per-share value through disciplined buybacks without a single quarter of deterioration across any qualitative criterion. Conviction: Conviction is held back by one unresolved dependency: the absence of any insider open-market purchases in the last 90 days, combined with the CEO's post-earnings 10b5-1 sale, provides no affirmative signal from management that the shares are undervalued at current levels despite the checklist sweep.
The Quality RationalistMental Models/Quality🟢 BullishMed
Signal: Mastercard is a toll booth on a growing road: the combination of a 5-year low P/E quartile, 46% net margins matched by 47% FCF margins with zero accrual games, and a 93.8% ROIC that requires almost no incremental capital to grow — all while the stock sulks at the bottom of its historical valuation band — is the The Quality Rationalist bargain appearing for the first time in years. Conviction: Conviction stays below full throttle because the current price is merely fair rather than cheap: a 15–20% drawdown on macro noise to the $460–$480 range, compressing the multiple toward 25x, would transform this from a reasonable purchase into an opportunity where I would be greedy.
The Forensic SkepticContrarian/Forensic⚫ NeutralLow
Signal: The business quality is genuine but the entry price is not: my DCF at 7% growth lands at $580, essentially today's price, while a normalized 25x P/E on $4.50 in earnings points to $450 — meaning the current quote already embeds above-average growth in perpetuity with no margin for multiple contraction or a consensus unwind. Conviction: Conviction in the neutral stance strengthens because three independent warning lights are flashing together: 93% analyst unanimity leaves narrow exits, the monthly MACD bearish crossover suggests fading momentum at a mature uptrend's top, and the CEO's post-earnings share sale — however routine — aligns with zero insider purchases across the last quarter.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All six panelists agree Mastercard's business quality is exceptional: a two-sided network moat with 46% net margins, 47% FCF conversion, and structural growth from global cash-to-digital migration.
- All six agree the tokenization push and value-added services (37% of revenue) are widening the moat, not just maintaining it.
- All six concur that interchange-fee regulation is the single existential threat, though none see it as an imminent catalyst.
- All six recognize that the current trailing P/E of 31x sits at the low end of Mastercard's own five-year range, creating a valuation entry that has been rare for this name.
The real debate
- The Intrinsic-Value Modeler sees a 31% discount to intrinsic value and calls it a genuine margin of safety, while The Forensic Skeptic applies a normalized 25x P/E and argues the stock is at best fairly priced with downside to $450 — the entire debate turns on whether Mastercard's premium multiple is structural or cyclical.
- The Quality Rationalist and The Scuttlebutt Growth Investor treat the monthly MACD bearish crossover as irrelevant noise for a decade-long compounder, while The Forensic Skeptic and The Moat Compounder read it as a warning that patience will be rewarded with a better entry.
- The GARP Operator and The Scuttlebutt Growth Investor view the 10b5-1 insider sales as mechanical non-events, while The Forensic Skeptic flags the absence of any open-market insider buying as a signal that management does not see deep undervaluation here.
The question it comes down to: Is Mastercard's current multiple — the low end of its own history but still a premium to the broad market — a structural discount that reflects permanent regulatory overhang, or a cyclical compression that will mean-revert higher as services revenue crosses 40% of the mix and the moat proves durable against alternative payment rails?
The bottom line
- Trigger to confirm the breakout: A weekly close above the all-time high at $601 would resolve the monthly MACD bearish crossover and signal that the uptrend is still in its early innings, not its late ones.
- Accumulation zone to watch: A pullback to the $530–$550 band, where the monthly EMA20 and weekly EMA50 cluster, compresses the trailing P/E toward 25–27x and would raise conviction across the panel materially.
- Risk level to monitor: A weekly close below $529.60 breaks both the monthly EMA20 and the weekly EMA50 simultaneously, confirming distribution and flipping the technical picture bearish regardless of fundamentals.
- Next catalyst: Q3 earnings in late October 2026 will test whether value-added services can cross 40% of total revenue — a threshold that would validate the margin-expansion thesis and potentially re-rate the multiple upward.
- Existential risk on the horizon: Any material interchange-fee legislation in the US or EU that impairs forward revenue guidance would invalidate the bull case across all six frameworks overnight, since the entire thesis rests on the toll-booth economics remaining intact.
contact@verdixhq.com · Published 2026-08-15 · Prices as of 2026-08-15 · Time horizon: 3–12 months · No direct position held in MA · MA verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s split verdict on MA — and where they disagree.
The case for and against roughly balance — no clear edge at today's price.
NYSE · Financials · 2026-08-22 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
BalancedMEDIUM confidence
Why
Mastercard's business earns a near-perfect score from all six investing archetypes on our panel, yet the stock lands at a BALANCED because four of them object on price alone, seeing no margin of safety at 32x earnings just 3.5% below the all-time high. The debate centers on whether paying a fair price for a great compounder is good enough, or whether waiting for a pullback to the $525-$533 zone is the smarter move.Level to watch
Key resistance 589.67+1.6% from 580.63
Next catalyst
Trigger to confirm the breakout: A weekly close above $602 on heavy volume would invalidate the resistance and confirm a new leg higher, likely drawing in the remaining cautious voices.The panel's take
Verdict: BALANCED · Conviction: MEDIUM · Last price: 580.63 · Changed from BUY
Panel: 2 Bullish · 4 Neutral · 0 Bearish → BALANCED
What changed since 2026-08-15:
- Price: 569.29 → 580.63 (+1.99%)
- Panel: 4 of 6 → 2 of 6 now Bullish — composition also changed: added The Asymmetric Bargainer, The Disruptive-Innovation Seeker; removed The Forensic Skeptic, The Quality Rationalist
- Trigger: A pullback into the $525–$533 support zone (weekly EMA20, monthly 23.6% Fibonacci, and the EMA cluster), where The Moat Compounder, The Asymmetric Bargainer, and the technical scout all agree the asymmetry becomes compelling enough for fresh capital. Alternatively, a weekly close above $602 confirming the breakout and invalidating the resistance that now caps the BALANCED.
- Verdict: BUY → BALANCED
The prior BUY at $569.29 was predicated on having meaningful runway before the $602 all-time high, but the subsequent rise to $580.63 compressed that gap to just 3.5%, largely evaporating the asymmetry. The standing trigger for a pullback to $530-$550 never fired, so no fresh capital was deployed at a better price, and the panel shifts to BALANCED on natural asymmetry compression.
The prior BUY at $569.29 appreciated to $580.63, compressing asymmetry to just 3.5% below the $601.77 all-time high. Every cautious vote — The Moat Compounder, The Intrinsic-Value Modeler, The Disruptive-Innovation Seeker, and The Asymmetric Bargainer — objects on price alone, not on Mastercard's business: they see a 10/10 moat and 46% net margins but no margin of safety at 32x earnings near the ATH. The GARP Operator and The Scuttlebutt Growth Investor call it a fair price for a great compounder and stay bullish, but with only 2 of 6 votes, the panel cannot reach the 3 needed for a directional call. The prior trigger (SELL below $529.60, conviction upgrade on a pullback to $530–$550) did not fire — price rose toward resistance without breaching either level — so the standing conditions remain in place while the verdict shifts from BUY to BALANCED on natural asymmetry compression.
Key levels
Key levels · MA
USD · as of 2026-08-22Analyst consensus target 667.3 USD · range 550–735
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key support at $533.07 is the weekly 50% Fibonacci retracement, aligning with the rising weekly EMA20 at $534.50 — this is the zone where The Moat Compounder, The Asymmetric Bargainer, and the technical scout all say the balance of upside to downside becomes compelling. Below it, $525.09 marks the monthly 23.6% Fibonacci, the last line before the Stage 2 uptrend structure is questioned. Key resistance at $601.77 is the all-time high and the monthly Fibonacci swing high, forming a confluence with the 52-week high of $601.62; price was rejected near this zone in the prior cycle and is now testing it again. The analyst consensus target of $667.30 sits well above resistance, confirming the Street sees value beyond the breakout.
What legendary investors think
We ran Mastercard past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue/Quality/Moat⚫ NeutralMed
Signal: Mastercard's two-sided network effects and 46% net margins with 60% operating margins make it a tollbooth on digital payments with a virtually unbreachable moat. Conviction: Conviction remains tempered by valuation: at 32x trailing earnings near the $602 all-time high, the margin of safety a moat investor demands simply is not there.
The GARP OperatorGrowth (GARP)🟢 BullishMed
Signal: With a PEG of 1.64, 14% revenue growth, and the stock passing the 'invest in what you know' test at every checkout counter, Mastercard fits the classic fast-grower profile at a reasonable price. Conviction: What bolsters conviction is the combination of an 80% earnings beat rate, upward guidance revisions, and $16.7B in free cash flow that covers the entire debt load in under a year.
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralLow
Signal: A DCF under reasonable assumptions (13% revenue growth tapering to 4% terminal, 58% target margins, 8.5% WACC) yields an estimated value of $560, placing Mastercard roughly 3.6% above intrinsic value. Conviction: Uncertainty around the sustainable growth rate holds conviction in check: the 16% consensus EPS growth forecast implies reinvestment levels that may be aggressive for a business that requires almost no capital to expand.
The Scuttlebutt Growth InvestorGrowth/Management🟢 BullishMed
Signal: The firm scores 12 of 15 on the quality checklist, with management's forward-leaning bets on agentic commerce and stablecoin partnerships signaling a culture that refuses to coast on the existing duopoly. Conviction: Conviction is held back because R&D intensity, labor relations, and management depth remain unverified through direct scuttlebutt, leaving three checklist items unresolved.
The Disruptive-Innovation SeekerDisruptive Innovation⚫ NeutralLow
Signal: Mastercard sits in the late majority of the core-payments S-curve, and while agentic commerce and stablecoin rails are interesting, they are incremental extensions of a mature network, not the exponential adoption curves that generate multi-bagger returns. Conviction: The absence of a Wright's Law dynamic and the lack of a probability-weighted TAM framework mean there is no quantifiable innovation thesis to underwrite, capping conviction at neutral.
The Asymmetric BargainerContrarian/Deep Value⚫ NeutralLow
Signal: The Dhandho framework scores just 2 of 4: the business is simple and high-quality, but at 32x earnings with consensus upside of only 15% against 25% plausible downside, the payoff is symmetric at best. Conviction: Superinvestor cloning data reinforces the caution: Akre Capital reduced its position in Q2 2026, and three other major holders exited entirely, signaling that the smart money does not see a bargain at these levels.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All six see Mastercard's business quality as exceptional: a wide network-effect moat, 46% net margins, and a duopoly position with Visa that no competitor can realistically challenge.
- All agree the balance sheet is strong despite the high debt-to-equity ratio, as $16.7B in free cash flow and 28x interest coverage make debt servicing trivial.
- The panel converges on $525-$533 as the zone where asymmetry improves. Even the bulls acknowledge it would be a more attractive price for deploying fresh capital.
- All recognize that regulatory risk (interchange fee caps, CBDCs) is the primary long-term threat to the model, though none see it as imminent.
The real debate
- The GARP Operator and The Scuttlebutt Growth Investor see a fair price for a great compounder and are willing to pay it, while The Moat Compounder and The Asymmetric Bargainer insist that a margin of safety must exist before capital is deployed, regardless of business quality.
- The Intrinsic-Value Modeler assigns a $560 intrinsic value (3.6% below market), while the consensus analyst target of $667 implies 15% upside, a gap that hinges entirely on whether terminal growth assumptions should be 3% or 4%.
- The Disruptive-Innovation Seeker sees a mature network in late-stage adoption where innovation is incremental, whereas The Scuttlebutt Growth Investor views the agentic commerce and stablecoin initiatives as genuine product development that extends the growth runway meaningfully.
The question it comes down to: Does the next 3.5% move to new highs mark the start of a fresh leg higher, or is it the final gasp before a pullback that finally offers the margin of safety the panel demands?
The bottom line
- Trigger to confirm the breakout: A weekly close above $602 on heavy volume would invalidate the resistance and confirm a new leg higher, likely drawing in the remaining cautious voices.
- Zone where conviction upgrades: A pullback into the $525-$533 support zone (weekly EMA20, monthly 23.6% Fibonacci, EMA cluster) would restore the margin of safety that The Moat Compounder, The Intrinsic-Value Modeler, and The Asymmetric Bargainer all require.
- Risk to monitor: Accelerating insider selling beyond the post-Q2 $54M from the CEO and CFO, especially if unaccompanied by any insider buying for another quarter, would signal management sees the stock as fully valued.
- Next catalyst: The Q3 2026 earnings report: if cross-border volume accelerates or value-added services margins expand materially, The Intrinsic-Value Modeler would raise growth and margin assumptions, potentially lifting intrinsic value above the current price.
contact@verdixhq.com · Published 2026-08-22 · Prices as of 2026-08-22 · Time horizon: 3–12 months · No direct position held in MA · MA verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel also debated